The nation of Zimbabwe has declined a substantial American health deal worth 367 million US dollars (272 million pounds) over five years over the United States' demand for confidential information.
This move came to light following a government memo dated December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "skewed".
An official spokesman has since clarified that the US was seeking health data for scientific study and commercial gain while was unwilling to share the benefits from future treatments.
"We will now turn to the challenging and unfortunate task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for further talks to reach a agreement acceptable to all parties so the country's vital HIV programme can proceed.
Broader Implications
This rejection follows a similar situation in neighbouring Kenya, where a court blocked a similar deal with the US following legal challenges were filed about the security of Kenyans' health data.
After returning to office last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had managed aid for the American government, but Trump argued its spending was "inefficient" and his government was pursuing direct bilateral deals to enhance transparency and responsibility.
According to statements, 16 nations in Africa have so far signed similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership might have yielded extraordinary benefits for Zimbabwean communities, especially the 1.2 million currently on HIV treatment via American-funded programmes," the Ambassador commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, without any corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Put simply, our country would provide the raw materials for medical research with no certainty that the resulting innovations would be accessible to our population should a new disease outbreak emerge."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining systems previously set up through the international organization.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage future pandemics.
"This system is intended to ensure that when a nation contributes its data, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how future collaboration could be designed in a way that honours the sovereignty and interests of each country."
Health Experts Response
Medical experts stated it understood the official position, but urged that negotiations should continue since much of the country's HIV programmes depended on external financing.
"If technical issues exist, such as those involving information security or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," the group added.
This impasse highlights the complex tensions between receiving crucial foreign assistance and protecting local interests in an increasingly data-driven world.